Vantage Hemp Co. Adopts C15 Solutions’ eQMSMarch 23, 2023
OVERVIEW OF THE MARKET The global cannabidiol (CBD) market was valued at 4.9 billion USD in 2021 and is projected to attain a value of 47.22 billion USD by 2028 at a compound annual growth rate (CAGR) of 21.3% during...
Vantage Hemp Co. Looks Ahead to 2023 After a Breakout Year in International Markets and New IndustriesDecember 14, 2022
Industry leader is now setting the bar beyond CBD (cannabidiol) with pharmaceutical-grade production and manufacturing for a variety of plant-based products Vantage Hemp Co. (“Vantage” or the “Company”), has continued to stand out in an ever-changing CBD industry through an...
Vantage Hemp Co. Establishes Softgel Production for White Label Partners and BeyondAugust 11, 2022
Pharmaceutical-grade CBD producer shows commitment to increasing white label format capabilities Industry leader, Vantage Hemp Co. (“Vantage” or the “Company”), announces softgel capabilities in response to meeting client and consumer demands. As the Company expands its white label and contract manufacturing services,...
Vantage Hemp Co. Submits a Drug Master File for CBD Distillate to the U.S. Food & Drug AdministrationApril 28, 2022
Vantage Hemp Co. further solidifies its position as an industry leader by its announcement of a DMF submission for its CBD distillate to the FDA.
Vantage Hemp Co. Launches Bulk Formulation ServicesMarch 28, 2022
Vantage Hemp is a highly accredited CBD extractor - one of North America’s leading hemp processors with both ICH Q7 and WHO GMP certified facilities.
World Leading Contract Manufacturing, White Label and FormulationsJanuary 26, 2022
Vantage delivers world leading contract manufacturing, white label, and formulation services to WHO GMP and ICH Q7 standards..
Vantage Hemp Co. is in the Final Stages of its DMF SubmissionsJanuary 26, 2022
As an active pharmaceutical ingredient (API) manufacturer, Vantage prepares for its DMF submissions to the FDA to support the quality and safety of its products.